APA (7th ed.) Citation

Sedykh, D. Y., Kashtalap, V. V., Khryachkova, O. N., Petrova, T. S., & Barbarash, O. L. (2022). Intensification of lipid-lowering therapy in very high-risk patients: Potential of combination with PCSK9 inhibitors. «FIRMA «SILICEA» LLC.

Chicago Style (17th ed.) Citation

Sedykh, D. Yu., V. V. Kashtalap, O. N. Khryachkova, T. S. Petrova, and O. L. Barbarash. Intensification of Lipid-lowering Therapy in Very High-risk Patients: Potential of Combination with PCSK9 Inhibitors. «FIRMA «SILICEA» LLC, 2022.

MLA (9th ed.) Citation

Sedykh, D. Yu., et al. Intensification of Lipid-lowering Therapy in Very High-risk Patients: Potential of Combination with PCSK9 Inhibitors. «FIRMA «SILICEA» LLC, 2022.